Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Report | 2023
Equity, Policy/Regulatory, Hospitals
This study aims to provide evidence of factors that impact participant reported serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (iOAT).
Original research | 2023
About PWUD, Mental health
To assess the associations of RAAM clinics with emergency department (ED) visits, hospitalizations, and mortality for people with problematic opioid use (POU).
Original research | 2023
Substitution/OAT, About PWUD, Mortality, Hospitals
Commentary | 2023
Evidence base, Policy/Regulatory, Hesitancy of prescribers , Equity
Report | 2023
Safer supply, Evidence base, Wrap-around services, Social services, Barriers and enablers
The Kitchener-Waterloo Safer Supply Program (SSP) opened in 2021 with funding from Health Canada’s Substance Use and Addiction Program, as one of the time-limited pilot programs that offers differe
Report | 2023
Safer supply, Evidence base, Housing, Poverty, Social benefits, Wrap-around services, Social services
This study aimed to understand the emergency department (ED) healthcare experiences of people who use substances (PWUS) with the intent of informing ways of improving the delivery of equitable care
Original research | 2023
About PWUD, About prescribers, Stigma, Hospitals
Case study | 2023
Chronic pain, Substitution/OAT, About PWUD, About prescribers
The aim of this study was to examine expert views on the effectiveness and implementability of state policies to improve engagement and retention in treatment for opioid use disorder (OUD).
Original research | 2023
About prescribers, Policy/Regulatory, Harm reduction
The objective of this analysis was to compare the efficacy and safety of 100-mg versus 300-mg maintenance doses of BUP-XR in OUD patients who inject opioids.
Original research | 2023
Substitution/OAT, Outcomes, About PWUD
To align with a person-centered care approach, iOAT can be embedded in sites that combine systems and services that have been historically fragmented and that address multiple comorbidities (integr
Original research | 2023
Wrap-around services
Commentary | 2023
Policy/Regulatory, Legal system/law enforcement, About PWUD, Barriers and enablers
This study aimed to characterize heroin-assisted treatment (HAT) patients at treatment start and compare their individual characteristics to those of patients entering traditional opioid maintenanc
Original research | 2023
Safer supply, Substitution/OAT, About PWUD, Overdose, Crime
Webpage | 2023
Parents/caregivers, About PWUD
La présente étude, qui s’inscrit dans le cadre d’activités permanentes de surveillance, donne un aperçu des incidents de surdose non mortelle survenus dans un établissement fédéral en 2020-2021.
Rapport | 2023
la surdose, le régime juridique / l'application de la loi
As part of ongoing monitoring efforts, the current study provides an overview of non-fatal overdose incidents that occurred in a federal institution in 2020-2021.
Report | 2023
Overdose, Legal system/law enforcement
To ensure bystanders’ willingness to carry and administer naloxone in response to a suspected overdose, it is critical to select products for community distribution with the highest likelihood of b
Original research | 2023
Overdose, Harm reduction
We characterize the capacity, barriers, and sustainment of mobile opioid use disorder (OUD) care services in a large city with a high incidence of OUD and HIV.
Original research | 2023
Barriers and enablers, Wrap-around services, Substitution/OAT, About prescribers
Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia
Commentary | 2023
Wrap-around services, Illegal drugs, Injecting drugs
Archived webinar | 2023
Safer supply, Policy/Regulatory, Decriminalization/legalization
